mRNA |
valdecoxib |
CTRPv2 |
pan-cancer |
AAC |
-0.029 |
0.4 |
mRNA |
Tamoxifen |
CTRPv2 |
pan-cancer |
AAC |
0.03 |
0.4 |
mRNA |
parbendazole |
CTRPv2 |
pan-cancer |
AAC |
-0.024 |
0.4 |
mRNA |
Methotrexate |
CTRPv2 |
pan-cancer |
AAC |
-0.029 |
0.4 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.4 |
mRNA |
leptomycin B |
CTRPv2 |
pan-cancer |
AAC |
-0.026 |
0.4 |
mRNA |
MK-2206 |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.4 |
mRNA |
16-beta-bromoandrosterone |
CTRPv2 |
pan-cancer |
AAC |
-0.029 |
0.4 |
mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.026 |
0.4 |
mRNA |
pandacostat |
CTRPv2 |
pan-cancer |
AAC |
0.029 |
0.4 |